DK3277821T3 - Fremgangsmåde til optimering af samling og produktion af hetero-multimere proteinkomplekser - Google Patents
Fremgangsmåde til optimering af samling og produktion af hetero-multimere proteinkomplekser Download PDFInfo
- Publication number
- DK3277821T3 DK3277821T3 DK16715820T DK16715820T DK3277821T3 DK 3277821 T3 DK3277821 T3 DK 3277821T3 DK 16715820 T DK16715820 T DK 16715820T DK 16715820 T DK16715820 T DK 16715820T DK 3277821 T3 DK3277821 T3 DK 3277821T3
- Authority
- DK
- Denmark
- Prior art keywords
- multimate
- hetero
- procedure
- production
- optimizing collection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562141009P | 2015-03-31 | 2015-03-31 | |
| PCT/EP2016/057147 WO2016156537A1 (en) | 2015-03-31 | 2016-03-31 | Method for optimizing the assembly and production of hetero-multimeric protein complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3277821T3 true DK3277821T3 (da) | 2019-10-28 |
Family
ID=55745749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16715820T DK3277821T3 (da) | 2015-03-31 | 2016-03-31 | Fremgangsmåde til optimering af samling og produktion af hetero-multimere proteinkomplekser |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10113193B2 (da) |
| EP (1) | EP3277821B1 (da) |
| JP (2) | JP6740244B2 (da) |
| CN (1) | CN108040485A (da) |
| AU (1) | AU2016239683B2 (da) |
| CA (1) | CA2981204C (da) |
| DK (1) | DK3277821T3 (da) |
| ES (1) | ES2752054T3 (da) |
| PT (1) | PT3277821T (da) |
| WO (1) | WO2016156537A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112566938A (zh) | 2018-06-03 | 2021-03-26 | 拉姆卡普生物测试有限公司 | 针对ceacam5和cd47的双特异性抗体 |
| EP3853377A4 (en) * | 2018-09-19 | 2022-10-05 | Totient, Inc. | ANTIBODY COMPOSITIONS ASSOCIATED WITH CANCER AND METHODS OF USE |
| MA56119A (fr) | 2019-06-07 | 2022-04-13 | Alx Oncology Inc | Procédés et réactifs pour réduire les interférences de médicaments se liant au cd47 dans des dosages sérologiques |
| WO2021053587A1 (en) | 2019-09-18 | 2021-03-25 | Klaus Strein | Bispecific antibodies against ceacam5 and cd3 |
| EP3831849A1 (en) | 2019-12-02 | 2021-06-09 | LamKap Bio beta AG | Bispecific antibodies against ceacam5 and cd47 |
| WO2022120286A1 (en) | 2020-12-06 | 2022-06-09 | ALX Oncology Inc. | Multimers for reducing the interference of drugs that bind cd47 in serological assays |
| EP4055055B1 (en) | 2020-12-18 | 2023-11-22 | LamKap Bio beta AG | Bispecific antibodies against ceacam5 and cd47 |
| WO2023242351A1 (en) | 2022-06-16 | 2023-12-21 | Lamkap Bio Beta Ag | Combination therapy of bispecific antibodies against ceacam5 and cd47 and bispecific antibodies against ceacam5 and cd3 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| US4551433A (en) | 1981-05-18 | 1985-11-05 | Genentech, Inc. | Microbial hybrid promoters |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| ATE135397T1 (de) | 1988-09-23 | 1996-03-15 | Cetus Oncology Corp | Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte |
| US5654173A (en) | 1996-08-23 | 1997-08-05 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| WO2006122822A2 (en) * | 2005-05-20 | 2006-11-23 | Lonza Biologics Plc. | High-level expression of recombinant antibody in a mammalian host cell |
| TWI586806B (zh) * | 2010-04-23 | 2017-06-11 | 建南德克公司 | 異多聚體蛋白質之製造 |
| RU2608640C2 (ru) | 2010-08-16 | 2017-01-23 | Новиммун С.А. | Способы получения мультиспецифичных и мультивалентных антител |
-
2016
- 2016-03-31 ES ES16715820T patent/ES2752054T3/es active Active
- 2016-03-31 WO PCT/EP2016/057147 patent/WO2016156537A1/en active Application Filing
- 2016-03-31 JP JP2017550891A patent/JP6740244B2/ja active Active
- 2016-03-31 CA CA2981204A patent/CA2981204C/en active Active
- 2016-03-31 EP EP16715820.3A patent/EP3277821B1/en active Active
- 2016-03-31 CN CN201680031476.9A patent/CN108040485A/zh active Pending
- 2016-03-31 DK DK16715820T patent/DK3277821T3/da active
- 2016-03-31 PT PT167158203T patent/PT3277821T/pt unknown
- 2016-03-31 US US15/086,736 patent/US10113193B2/en active Active
- 2016-03-31 AU AU2016239683A patent/AU2016239683B2/en active Active
-
2018
- 2018-09-28 US US16/146,491 patent/US20190226001A1/en not_active Abandoned
-
2020
- 2020-03-03 JP JP2020035849A patent/JP2020096641A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20190226001A1 (en) | 2019-07-25 |
| EP3277821A1 (en) | 2018-02-07 |
| US20160289727A1 (en) | 2016-10-06 |
| PT3277821T (pt) | 2019-10-31 |
| US10113193B2 (en) | 2018-10-30 |
| CN108040485A (zh) | 2018-05-15 |
| CA2981204A1 (en) | 2016-10-06 |
| AU2016239683A1 (en) | 2017-10-19 |
| JP6740244B2 (ja) | 2020-08-12 |
| CA2981204C (en) | 2023-09-19 |
| ES2752054T3 (es) | 2020-04-02 |
| EP3277821B1 (en) | 2019-07-24 |
| JP2020096641A (ja) | 2020-06-25 |
| JP2018509922A (ja) | 2018-04-12 |
| AU2016239683B2 (en) | 2022-02-03 |
| WO2016156537A1 (en) | 2016-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3277821T3 (da) | Fremgangsmåde til optimering af samling og produktion af hetero-multimere proteinkomplekser | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3265947T3 (da) | Fremgangsmåde og system til kryptering | |
| DK3215601T3 (da) | Fremgangsmåder til transduktion og celleforarbejdning | |
| DK3250610T3 (da) | Fcrn-antistoffer og fremgangsmåder til anvendelse heraf | |
| DK3003699T3 (da) | Fodtøjsgenstand og fremgangsmåden til dannelse af genstanden | |
| DK3205119T3 (da) | Høreapparat system og metode | |
| DK3201336T3 (da) | Fremgangsmåder til ekstrahering og oprensning af ikke-denaturerede proteiner | |
| DK3586645T3 (da) | System og fremgangsmåde til fremstilling af et ekstruderet proteinprodukt | |
| DK3025077T4 (da) | Membran og fremgangsmåde til fremstilling af denne | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3467904T3 (da) | Separator med høj vådbarhed og fremgangsmåde til fremstilling deraf | |
| DK3074544T3 (da) | Martensitholdigt rustfrit stål, stykke udført i dette stål og fremgangsmåde til fremstilling heraf | |
| DK3094640T3 (da) | Fremgangsmåder til steril kromatografi og fremstilling | |
| DK3368578T3 (da) | Anti-HtrA1-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3152569T3 (da) | Midler og fremgangsmåder til bestemmelse af t-cellegenkendelse | |
| DK3110446T3 (da) | Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme | |
| DK3400321T3 (da) | System til produktion af dihydrogen og tilhørende fremgangsmåde | |
| DK3040108T3 (da) | Fremstillingsfremgangsmåde til koncentreret produkt under anvendelse af membran-koncentrationsfremgangsmåde og fryse-koncentrationsfremgangsmåde | |
| DK3277742T3 (da) | Fluorescerende siloxanelastomer, fremgangsmåde til fremstilling af denne og anvendelsen | |
| DK3137616T3 (da) | Forøgelse af cellulær lipid produktion ved forøgelse af aktiviteten af diacylglycerolacyltransferase og formindskelse af aktiviteten af triacylglycerollipase | |
| DK3380496T3 (da) | Forbedret proteinproduktion og fremgangsmåder hertil | |
| DK3121318T3 (da) | Beklædningsgenstand og fremgangsmåde til fremstilling | |
| DK3384045T3 (da) | Fremgangsmåde til bestemmelse af celleklonalitet |